Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary Events

American Journal of Cardiology

Volumn 98, Issue 9, 2006, Pages 1156-1159

  Marcucci, Rossella ^a,b   Paniccia, Rita ^a,b   Antonucci, Emilia ^a,b   Gori, Anna Maria ^a,b   Fedi, Sandra ^a,b   Giglioli, Cristina ^a   Valente, Serafina ^a   Prisco, Domenico ^a,b   Abbate, Rosanna ^a,b   Gensini, Gian Franco ^a,b,c  

^a Azienda Ospedaliero ^*  (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; COLLAGEN; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGE DETERMINATION; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTOLE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 33750039353     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.041     Document Type: Article

References (16)

1. Antithrombotic Trialist Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 324 (2002) 71-86
2. Whang T.H., Bhatt D.L., and Topol E.J. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 27 (2006) 647-654
3. Bhatt D.L. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol 43 (2004) 1127-1129
4. Hankey G.L., and Eikelboom J.W. Aspirin resistance. BMJ 328 (2004) 477-479
5. Chen W.H., Lee P.Y., Ng W., Tse H.F., and Lau C.P. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary interventions despite clopidogrel pre-treatment. J Am Coll Cardiol 43 (2004) 1122-1126
6. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., and Topol E.J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
7. Eikelboom J.W., Hirsch J., Weitz J.I., Johnston M., Yi Q., and Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105 (2002) 1650-1655
8. Chen W.H., Lee P.Y., Ng W., Kwok J.Y.Y., Cheng X., Wai-Luen Lee S., Tse H.F., and Lau C.P. Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention. Am J Cardiol 96 (2005) 760-763
9. Wenaweser P., Dorffler-Melly J., Imboden K., Windecker S., Togni M., Meier B., Haeberli A., and Hess O.M. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752 :45
10. Ajzenberg N., Aubry P., Huisse M.G., Cachier A., El Amara W., Feldman L.J., Himbert D., Baruch D., Guillin M.C., and Steg G. Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis. J Am Coll Cardiol 45 (2005) 1753-1756
11. Hankey G.J., and Eikelboom J.W. Aspirin resistance. Lancet 367 (2006) 606-617
12. Borna C., Lazarowski E., van Heusden C., Ohlin H., and Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 26 (2005) 3-10
13. Rasmanins G., Vesterqvist O., Green K., Edhag O., and Henriksson P. Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction. Lancet 2 (1988) 245-247
14. Heper G., and Bayraktaroglu M. The importance of von Willebrand factor level and heart rate changes in acute coronary syndromes: a comparison with chronic ischemic conditions. Angiology 54 (2003) 27-39
15. Andreotti F., Lefroy D.C., Sciahbasi A., Crake T., Maseri A., Marco E., and Davies G.J. Platelet and thrombin activity following cardiac catheterization despite treatment with aspirin. J Thromb Thrombolysis 6 (1998) 141-145
16. Prisco D., Antonucci E., Fedi S., Margheri M., Giglioli C., Comeglio M., Lombardi A., Chioccioli M., Abbate R., and Gensini G.F. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction. A pilot study. Clin Exp Med 1 (2001) 219-224